Exclusive articles:
YRC Worldwide (YRCW) Gets Upgraded to ‘Buy’
In New York upgraded the stock to 'buy' from sell this week based on the drop in the company's stock price. Mr. Crystall has a short-term price target of .55 to .70 cents a share.
Adventrx Pharmaceuticals (ANX) Submits Cancer Drug to NDA Amid Takeover Rumors
If approved, ANX-530 threatens to take market share away from several bigger pharmaceutical companies, including GlaxoSmithKline.
Cord Blood Saves Child’s Life!
CorCell was the FIRST company to have stored a sample that was transplanted and thus integral in the cure of childhood leukemia.
